APPLICATIONS PUBLISHED 2 OCTOBER 2002
Published: 1-Mar-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Method and formulations for the efficient delivery of water-insoluble drugs by nebuliser
Cofman, Robert E 1244426*
Pharmaceutical compsns for oral administration
Capsulis 1244427*
Pharmaceutical superdisintegrant
Edward Mendell 1244428*
Controlled release KCI tablet formulations
Eurand America 1244429*
Coating system
Wyeth 1244430*
Transdermal administration of reboxetine
Pharmacia 1244431*
Methods for pulmonary delivery of interleukin-2
Chiron Corp 1244432*
Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule
Euroscreen 1244433*
Use of chemotherpeutic agents
Schultz, Hans-Hermann 1244434*
Polyhydrated aromatic compounds for the treatment of amyloidosis as a-synuclein fibril diseases
Proteotech 1244435*
Compounds and compsns for use in inhibiting andoparastitic fatty acid biosynthesis
University College Cardiff Consultants 1244436*
Tertiary amino compounds having opioid receptor affinity
Euro-Celtique 1244437*
Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
Alcon 1244438*
Oral glutamine in the prevention of neonatal necrotising enterocolitis and other gastrointestinal mucosal damage
Probiotix 1244439*
Agonists specific for the peripheral cannabinoid receptor
Yissum Research Development Company, Hebrew University of Jerusalem 1244440*
Use of trimebutine for treating pain
Warner-Lambert 1244441*
Method for detecting nucleotide synthesis inhibitors having fewer side effects
Aventis Pharma Deutschland 1244442*
Method for increasing the concentration of ascorbic acid in brain tissues of a subject
Sloan-Kettering Institute for Cancer Research 1244443*
Process for the formulation of carbapenem antibiotic compsns
Merck 1244444*
Use of azoles for preventing skin cancer
Bayer 1244445*
Thrombopoietin mimetics
SmithKline Beecham 1244446*
Novel methods and compsns involving opioids and antagonists thereof
Adolor Corp 1244447*
Novel methods for the treatment and prevention of ileus
Adolor Corp 1244448*
Use of ketotiofen as a phthalmic agent
Novartis 1244449*
8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
Merck 1244450*
Substituted piperazine and piperidine calcium channel blockers
Neuromed Technologies 1244451*
Urotensin-II receptor antagonists
SmithKline Beecham 1244452*
Method and compsn for the treatment of pain
AstraZeneca 1244453*
Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
Aventis Pharma Deutschland 1244454*
Methods of treating vascular diseases characterised by nitric oxide insufficiency
Nitromed 1244455*
A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
UCB 1244456*
Methods and compsns related to modulators of annexin and cartilage homeostasis
Glaxo Group; Rush-Presbyterian-St Luke's Medical Centre 1244457*
Weight promoting compsn, method, and product
Pherin Pharmaceuticals 1244458*
Treatment of drug-resistant human immunodeficiency virus infection
The Regents of the University of California 1244459*
Treatment based on the discovery that nitric oxide synthase is a paraquat diaphorase
Duke University; Cornell Research Foundation 1244460*
Pharmaceutical compsn comprised of spider venoms, the production thereof, and its use for treating tumour diseases
Toximed 1244462*
